Pharmacogenomics – The Future of Precision Drug Therapy

(Anthropology Paper-I: Human Genetics, Chromosomal Aberrations, DNA Profiling)

Background – Why Pharmacogenomics Matters

For decades, healthcare followed a one-size-fits-all approach.
But every human body responds differently to medicines due to genetic variation.
This is why some patients benefit from a drug, others face side effects, and some see no improvement at all.

Pharmacogenomics changes this by using a person’s genetic profile to decide:

• which medicine is best,
   
• what dose is safe,
   
• and whether a drug will cause harm.
   

Adverse Drug Reactions (ADRs) are a major cause of hospitalisation.
Pharmacogenomics helps predict and prevent them.

How Genes Influence Drug Response

Cytochrome P450 (CYP) Genes – The Real Game Changers

Nearly 75% of common medicines are processed by CYP enzymes.
Variations create metabolic types:

• Poor Metaboliser (PM): drug stays too long → toxicity
   
• Normal Metaboliser: normal effect
   
• Ultra-Rapid Metaboliser (UM): drug breaks too fast → no benefit
  90% people carry at least one gene variant affecting drug response.

Real-World Examples (Perfect for Case Studies)

a) Warfarin – Blood Thinner

• Highly sensitive drug, narrow safety limits.
   
• Variants in CYP2C9 & VKORC1 explain 50% of dose differences.
   
• Gene-guided dosage reduces bleeding and speeds recovery.
   

b) Clopidogrel (Heart Patients)

• Needs CYP2C19 for activation.
   
• Variant CYP2C192* (25–30%) → ineffective drug → higher risk of heart attack.
   
• 2022 guidelines recommend alternative medicines for such patients.
   

c) Psychiatry

Antidepressants depend on CYP2D6, CYP2C19.
Testing reduces side effects and ensures quicker recovery.

d) Cancer Treatment

• DPYD testing before 5-Fluorouracil prevents life-threatening reactions.
   

e) Preventing Severe Drug Reactions

• HLA-B*57:01 → prevents allergic reaction to Abacavir
   
• HLA-B*15:02 → prevents Carbamazepine-induced SJS
   

Cost & Public Health Impact

• Genetic tests cost $200–500 today (earlier thousands).
   
• Saves cost by reducing hospitalisation, ADRs, and trial-and-error treatment.
   
• A single test can guide prescriptions for a lifetime.
   

Most useful for:

• heart disease
   
• depression
   
• epilepsy
   
• chronic pain
  Less useful for short-term illnesses.
   

Challenges in Implementation

a) Doctor Awareness

Many clinicians aren’t trained in interpreting genetic reports.

b) Digital Systems

Electronic Health Records (EHR) lack genetic-based alerts.

c) Insurance Gaps

Tests may not be covered; patients pay out of pocket.

d) Regulatory Issues

Over 100 FDA drug labels mention genetic factors, but clarity is limited.

e) Institutional Resistance

Changing old prescribing habits is slow.

What the Future Looks Like

• Pre-emptive genetic testing for all.
   
• EHR-integrated Clinical Decision Support Systems (CDSS).
   
• Whole-genome sequencing may become routine.
   
• India can push precision health under the Ayushman Bharat Digital Mission.
   

UPSC Relevance

Governance & Public Health

• Reduces healthcare burden by minimising ADRs.
   
• Supports evidence-based medicine.
   

Science & Technology

• Combines genetics, AI, and clinical systems.
   
• Boosts India’s biotech sector.
   

Ethics

• Privacy, data protection, genetic discrimination concerns.
   

Economics

• Cost-effective for a large population like India.
   

Conclusion

Pharmacogenomics moves healthcare from guesswork to precision.
It ensures safer, smarter, personalised drug treatment and will soon be a core pillar of modern medicine.